搜索临床试验以:Ranibizumab 0.5Mg/0.05Ml Oph 注射液
总计368个结果
-
Novartis Pharmaceuticals终止
-
Leonard Feiner, MD, PhDNJ Retina (Retina Associates of New Jersey)完全的
-
Novartis Pharmaceuticals完全的年龄相关性黄斑变性 | 脉络膜新生血管大韩民国, 克罗地亚, 德国, 印度, 俄罗斯联邦, 火鸡, 英国, 埃及, 以色列, 比利时, 丹麦, 匈牙利, 斯洛文尼亚, 西班牙, 瑞士, 意大利, 葡萄牙, 斯洛伐克, 智利
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...招聘中
-
Jiangsu Province Centers for Disease Control and...Bejing Vigoo Biological Co., LTD完全的
-
Universitair Ziekenhuis Brussel招聘中
-
Jiangsu Province Centers for Disease Control and...Shandong Hengye Biotech Co., Ltd.完全的
-
Jiangsu Nhwa Pharmaceutical Co., Ltd.招聘中
-
Zhongshan Ophthalmic Center, Sun Yat-sen University完全的
-
Shenzhen Kangtai Biological Products Co., LTDGuangdong Provincial Institute of Biological Products And Materia Medica未知
-
AllerganMAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan完全的
-
Kyushu UniversityNovartis; Kurume University; Fukuoka University; University of Occupational and Environmental Health 和其他合作者未知
-
Oxurion完全的
-
Linda Van EldikDuke Clinical Research Institute; Alzheimer's Association完全的
-
CanSino Biologics Inc.Jiangsu Province Centers for Disease Control and Prevention完全的
-
Taipei Veterans General Hospital, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Changhua Christian Hospital未知慢性乙型肝炎
-
BayerUniversity of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology...完全的
-
Massachusetts General HospitalUnited States Department of Defense招聘中
-
GlaxoSmithKline完全的
-
St. Joseph's Healthcare HamiltonPfizer; McMaster University未知睡觉 | 绝经 | 抑郁、焦虑
-
Novartis Pharmaceuticals完全的继发于病理性近视 (PM) 的脉络膜新生血管 (CNV) 导致的视力障碍中国, 印度, 泰国, 香港, 大韩民国, 菲律宾
-
Praxis Precision Medicines招聘中
-
Arizona State UniversityNational Institute on Drug Abuse (NIDA); Pfizer; University of Nevada, Reno; Los Angeles Clinical...完全的
-
London School of Hygiene and Tropical MedicineRadboud University Medical Center; Centre national de recherche et de formation sur le paludisme完全的